See inside every stock. Pro
WatchlistPro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.36▲ 0.89%

Direxion Daily Healthcare Bull 3X (CURE)

Leveraged ETF · Direxion · NYSE ARCA · 67 holdings
$159.07 ▲ +6.06 (3.96%)
At close · USD · Volume 92,590
Returns and riskCostIncomeDividend historyHoldingsX-Ray look-throughQuestions
52-week range
$82.41 – $161.27
Day's range
$154.10 – $161.27
1-year total return
+68.7%
Leveraged fund (3x, by its name). The stated multiple applies to one day. It resets daily, so returns over longer periods can differ a lot from the multiple, and the figures below describe the past only.

CURE price chart

Daily, split-corrected, distributions markedEnd-of-day prices

CURE fund facts

FundDirexion Daily Healthcare Bull 3X Shares
TickerCURE · NYSE ARCA
Issuer (by our rules)Direxion
Category (by our rules)Leveraged
Expense ratioNot in our sources
Holdings67
Net assets (fund, SEC)$172M
Yield (last 12 months)0.79%
DistributionsQuarterly
52-week range$82.41 – $161.27
Average volume (3 months)58,984
First price in our data15 Jun 2011
Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.

Returns and risk

1 month
+19.7%
3 months
+42.2%
6 months
+77.0%
Year to date
+44.0%
1 year
+68.7%
3 years a year
+24.2%
5 years a year
+7.4%
10 years a year
+19.6%
Volatility (1 year)
48.0%
Largest drop, last year
−31.1%
Largest drop in our data
−69.2%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 22 Oct 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.

Cost: expense ratio

We could not match an expense ratio for CURE in the SEC prospectus data we read. Funds structured as trusts or notes, and very new funds, are often missing. We show nothing rather than a guess; the issuer's fact sheet has the figure.

Income: distributions

Paid, last 12 months
1.26 USD
Yield on today's price
0.79%
Frequency
Quarterly
Latest ex-date
22 Sep 2026
Full CURE dividend history →
Cash paid per current share (restated for share splits), before tax, from EODHD.

CURE top holdings

#HoldingWeight
1 DREYFUS 18.79%
2 ELI LILLY & COMPANY LLY 10.41%
3 N/A 8.28%
4 GOLDMAN SACHS LIQ ES FD A 8.19%
5 GOLDMAN FINANCIAL 7.51%
6 JOHNSON & JOHNSON JNJ 7.07%
7 ABBVIE INC ABBV 5.08%
8 UNITEDHEALTH GROUP INC UNH 4.31%
9 MERCK & COMPANY INC MRK 3.68%
10 N/A 3.34%
The top 10 make up 76.7% of the fund, out of 67 holdings.
Positions as of 31 Jul 2026, from the fund's Form N-PORT filed with the SEC. Public N-PORT holdings are quarter-end positions published about 60 days later, so they can be months old and the fund may have changed since.

X-Ray look-through

StocksXray scores 67% of CURE by weight (59 stocks in our S&P 500 coverage), so we can look inside the fund with our own numbers. The weighted average X-Ray Score of those stocks is 50 out of 100.

Undervalued 12%Fair 78%Overvalued 10%
Health Care 100%
Weights are the SEC holdings weights dated 31 Jul 2026; scores and fair-value labels are today's. Labels follow our fair-value method ("Undervalued" means fair value is more than 17.5% above the price) and are model estimates, not forecasts or advice. How the X-Ray Score works.

Similar Leveraged ETFs

AXTQ Tradr 2X Short AXTI Daily– 1y IONX Defiance Daily Target 2X Long...1.29% fee · −89.8% 1y UNHG Leverage Shares 2X Long UNH Da...0.77% fee · +10.2% 1y DFEN Daily Aerospace & Defense Bull...−28.1% 1y ROBN T-REX 2X Long HOOD Daily Targe...1.05% fee · −70.9% 1y CRMG Leverage Shares 2X Long CRM Da...0.78% fee · −31.2% 1y All leveraged ETFs →
Funds of the same category, nearest in trading size. Similar does not mean equivalent: check holdings and costs.

CURE: frequently asked questions

What is CURE?

CURE is the Direxion Daily Healthcare Bull 3X ETF, issued by Direxion, listed on NYSE ARCA. By our rules it is classed as "Leveraged". Its latest SEC filing lists 67 holdings.

Does CURE pay dividends?

Yes. CURE paid 1.26 per share over the last 12 months, quarterly, a trailing yield of 0.79% on today's price. The latest ex-dividend date was 22 Sep 2026.

What does CURE hold?

The largest holdings in the latest SEC filing are DREYFUS (18.8%), ELI LILLY & COMPANY (10.4%), N/A (8.3%). The top 10 together make up 76.7% of the fund.

How has CURE performed?

Total return including distributions to 22 Oct 2026: 1 year +68.7%, 3 years +24.2% a year, 5 years +7.4% a year. Past performance does not guarantee future results.

Is CURE leveraged?

By its name CURE aims for 3x the daily return of its target. The multiple resets every day, so returns over weeks or months can differ a lot from the stated multiple, and losses can compound. Funds like this are designed for short holding periods.

How does StocksXray rate the stocks inside CURE?

We score 67% of the fund by weight (59 stocks) with our X-Ray Score: the weighted average is 50 out of 100. These are model estimates, not forecasts or advice.

Where the numbers come from

Prices and distributions end-of-day data from EODHD; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
Read the methodology →

StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.